Cargando…
High-dose-rate interstitial brachytherapy with hypoxic radiosensitizer KORTUC II for unresectable pelvic sidewall recurrence of uterine cervical cancer: a case report
In order to improve oncologic outcomes in radiotherapy treatments of patients with unresectable pelvic sidewall recurrences of uterine cervical cancer, we combined high-dose-rate interstitial brachytherapy (HDR-ISBT) with newly tested hypoxic radiosensitizer Kochi oxydol-radiation therapy for unrese...
Autores principales: | Nakata, Mio, Yoshida, Ken, Shimbo, Taiju, Yoshikawa, Nobuhiko, Yoshioka, Hiroto, Hori, Akihiro, Sato, Chikara, Uesugi, Yasuo, Kogata, Yuhei, Masui, Koji, Murakami, Naoya, Kashihara, Tairo, Akiyama, Hironori, Tselis, Nikolaos, Ohmichi, Masahide, Nihei, Keiji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787211/ https://www.ncbi.nlm.nih.gov/pubmed/33437310 http://dx.doi.org/10.5114/jcb.2020.101695 |
Ejemplares similares
-
New enzyme-targeting radiosensitizer (KORTUC II) treatment for locally advanced or recurrent breast cancer
por: Shimbo, Taiju, et al.
Publicado: (2021) -
KORTUC, a novel hydrogen peroxide‑based radiosensitizer for the enhancement of brachytherapy in patients with unresectable recurrent uterine cervical cancer
por: Shimbo, Taiju, et al.
Publicado: (2023) -
Non-Surgical Breast-Conserving Treatment (KORTUC-BCT) Using a New Radiosensitization Method (KORTUC II) for Patients with Stage I or II Breast Cancer
por: Ogawa, Yasuhiro, et al.
Publicado: (2015) -
A new implant device to prevent edema-associated underdosage in high-dose-rate interstitial brachytherapy of mobile tongue cancer
por: Yoshida, Ken, et al.
Publicado: (2019) -
Effect of a lead block on alveolar bone protection in image-guided high-dose-rate interstitial brachytherapy for tongue cancer: using model-based dose calculation algorithms to correct for inhomogeneity
por: Akiyama, Hironori, et al.
Publicado: (2022)